Cargando…

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect

In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasiveness in vitro and caused a decrease in the expression of a set of proteins specifically involved in growth, invasion and angiogenesis. In addition, CBD treatment caused a dose-related down-regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solinas, Marta, Massi, Paola, Cinquina, Valentina, Valenti, Marta, Bolognini, Daniele, Gariboldi, Marzia, Monti, Elena, Rubino, Tiziana, Parolaro, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804588/ https://www.ncbi.nlm.nih.gov/pubmed/24204703 http://dx.doi.org/10.1371/journal.pone.0076918

Ejemplares similares

Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress
por: Massi, Paola, et al.
Publicado: (2010)

Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition
por: Rubino, Tiziana, et al.
Publicado: (2011)

Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
por: Martínez, Vicente, et al.
Publicado: (2020)

Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
por: Kozela, Ewa, et al.
Publicado: (2015)

Sex-Dependent Vulnerability to Cannabis Abuse in Adolescence
por: Rubino, Tiziana, et al.
Publicado: (2015)

Understanding Cannabinoid Psychoactivity with Mouse Genetic Models
por: Mackie, Ken
Publicado: (2007)

Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
por: Merrick, John, et al.
Publicado: (2016)

Cannabidiol and Other Cannabinoids in Demyelinating Diseases
por: Navarrete, Carmen, et al.
Publicado: (2021)

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Role of endocannabinoids in regulating drug dependence
por: Parolaro, Daniela, et al.
Publicado: (2007)

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
por: Kozela, Ewa, et al.
Publicado: (2017)

Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high
por: Chicca, A., et al.
Publicado: (2018)

Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
por: Gabaglio, Marina, et al.
Publicado: (2021)

Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material
por: Pasin, Daniel, et al.
Publicado: (2022)

Non-Psychoactive Cannabinoid Modulation of Nociception and Inflammation Associated with a Rat Model of Pulpitis
por: Laks, Elana Y., et al.
Publicado: (2023)

Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function
por: Zhang, Liying, et al.
Publicado: (2022)

Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition
por: Zamberletti, Erica, et al.
Publicado: (2022)

A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy
por: Katz, Daphna T., et al.
Publicado: (2023)

Compte rendu de la reunion 98 d'aspects operationnels du 26/11/87
por: Boillot, J
Publicado: (1987)

Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
por: Zamberletti, Erica, et al.
Publicado: (2019)

Transition-based reweighting and neural rational inference analysis of effects of new psychoactive substances on cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2023)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabissativa
por: Suttithumsatid, Wiwit, et al.
Publicado: (2022)

A Case of Status Epilepticus and Transient Stress Cardiomyopathy Associated with Smoking the Synthetic Psychoactive Cannabinoid, UR-144
por: Fawaz, Sarah Al, et al.
Publicado: (2019)

Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide
por: Maszczyk, Mateusz, et al.
Publicado: (2022)

Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
por: Kozela, Ewa, et al.
Publicado: (2016)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
por: Mammana, Santa, et al.
Publicado: (2019)

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009)

Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity
por: Cheng, Wen-Yu, et al.
Publicado: (2013)

Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
por: Ravizza, Raffaella, et al.
Publicado: (2004)

Targeting Mitochondrial ROS Production to Reverse the Epithelial-Mesenchymal Transition in Breast Cancer Cells
por: Monti, Elena, et al.
Publicado: (2022)

Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension
por: Remiszewski, Patryk, et al.
Publicado: (2022)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Cannabis sativa (Henola Variety) Inflorescences
por: Stasiłowicz-Krzemień, Anna, et al.
Publicado: (2023)

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB(2) Receptors
por: Martínez-Pinilla, Eva, et al.
Publicado: (2017)

Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review
por: Trac, Judy, et al.
Publicado: (2021)

Use of (13)C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis sativa L. (Hemp)
por: Marchetti, Lucia, et al.
Publicado: (2019)

Disruption of hippocampal synaptic transmission and long‐term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ(9)‐tetrahydrocannabinol
por: Hoffman, Alexander F., et al.
Publicado: (2016)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
por: González, Débora, et al.
Publicado: (2015)

Prescription of psychoactive drugs in patients attended by the SUS at Manhuaçu - MG (Brazil)
por: Gonçalves, Daniel P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_iupsbdlkdo6mg58ndcaf42sp8s